Lunch Webinar Discussie 'Why invest in Healthcare Innovations?'
-
Harry Geels
Senior Investment Advisor, Auréus
Harry Geels is werkzaam bij Auréus als Senior Investment Adviseur. Hij is daar medeverantwoordelijk voor de research naar en selectie van beleggingsfondsen. Ook is hij Adjunct-Hoofdredacteur van Financial Investigator. Hij is verder parttime Docent bij het Actuarieel Instituut. Geels behaalde in 1994 zijn Master Financiële Economie aan de VU Amsterdam. Hij schrijft zijn columns voor Financial Investigator op persoonlijke titel. -
Laura Nelson Carney
Equity Investment Analyst & Research Director, Capital Group
Laura Nelson Carney is an equity investment analyst and research director at Capital Group, with research responsibility for pharmaceutical and biotechnology companies in Europe and Asia. She has nine years of investment industry experience and has been with Capital Group for six years. Prior to joining Capital, Nelson Carney worked as an equity research analyst at Sanford C. Bernstein, covering Asia-Pacific healthcare. Before that, she was a management consultant at McKinsey & Company, a research scientist at Merck and a postdoctoral fellow at Imperial College London. She holds a PhD in neurosciences from Imperial College London and a bachelor's degree in human biology from Stanford University.